| Dr Emily Hwang Kim, OD | |
|
11511 Ne 10th St, Bellevue, WA 98004-8578 | |
| (425) 502-3000 | |
| (425) 502-3589 |
| Full Name | Dr Emily Hwang Kim |
|---|---|
| Gender | Female |
| Speciality | Optometry |
| Experience | 17 Years |
| Location | 11511 Ne 10th St, Bellevue, Washington |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1225229388 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 152W00000X | Optometrist | OPT 13330T (California) | Secondary |
| 152W00000X | Optometrist | OD61206736 (Washington) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Kaiser Foundation Health Plan Of Washington | 9032022579 | 1480 |
News Archive
In a striking, unexpected discovery, researchers at Albert Einstein College of Medicine of Yeshiva University have determined that vitamin C kills drug-resistant tuberculosis bacteria in laboratory culture.
MedDay, a biotechnology company focused on the treatment of nervous system disorders, reports additional positive data from its pivotal Phase III clinical trial, MS-SPI, with MD1003, a highly-concentrated pharmaceutical grade biotin, in patients with Progressive Multiple Sclerosis.
In an early step toward letting severely paralyzed people speak with their thoughts, University of Utah researchers translated brain signals into words using two grids of 16 microelectrodes implanted beneath the skull but atop the brain. "We have been able to decode spoken words using only signals from the brain with a device that has promise for long-term use in paralyzed patients who cannot now speak," says Bradley Greger, an assistant professor of bioengineering.
Researchers from Chronix Biomedical and The University of Texas MD Anderson Cancer Center today announced that results from a pilot study demonstrating the utility of cell-free DNA (cfDNA) blood tests as a companion diagnostic for breast cancer patients are to be reported in a poster presentation titled "Modulation of breast cancer cell-free DNA with surgical resection" (Abstract #11060) at the American Society of Clinical Oncology Annual Meeting (ASCO 2013) being held from May 31 through June 4, 2013 in Chicago. The blood test detects cfDNA that is released into the blood stream by damaged and dying cancer cells.
› Verified 4 days ago
| Provider Name | Kaiser Foundation Health Plan Of Washington |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1396810701 PECOS PAC ID: 9032022579 Enrollment ID: O20031112000454 |
News Archive
In a striking, unexpected discovery, researchers at Albert Einstein College of Medicine of Yeshiva University have determined that vitamin C kills drug-resistant tuberculosis bacteria in laboratory culture.
MedDay, a biotechnology company focused on the treatment of nervous system disorders, reports additional positive data from its pivotal Phase III clinical trial, MS-SPI, with MD1003, a highly-concentrated pharmaceutical grade biotin, in patients with Progressive Multiple Sclerosis.
In an early step toward letting severely paralyzed people speak with their thoughts, University of Utah researchers translated brain signals into words using two grids of 16 microelectrodes implanted beneath the skull but atop the brain. "We have been able to decode spoken words using only signals from the brain with a device that has promise for long-term use in paralyzed patients who cannot now speak," says Bradley Greger, an assistant professor of bioengineering.
Researchers from Chronix Biomedical and The University of Texas MD Anderson Cancer Center today announced that results from a pilot study demonstrating the utility of cell-free DNA (cfDNA) blood tests as a companion diagnostic for breast cancer patients are to be reported in a poster presentation titled "Modulation of breast cancer cell-free DNA with surgical resection" (Abstract #11060) at the American Society of Clinical Oncology Annual Meeting (ASCO 2013) being held from May 31 through June 4, 2013 in Chicago. The blood test detects cfDNA that is released into the blood stream by damaged and dying cancer cells.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Emily Hwang Kim, OD 11511 Ne 10th St, Bellevue, WA 98004-8578 Ph: (425) 502-3000 | Dr Emily Hwang Kim, OD 11511 Ne 10th St, Bellevue, WA 98004-8578 Ph: (425) 502-3000 |
News Archive
In a striking, unexpected discovery, researchers at Albert Einstein College of Medicine of Yeshiva University have determined that vitamin C kills drug-resistant tuberculosis bacteria in laboratory culture.
MedDay, a biotechnology company focused on the treatment of nervous system disorders, reports additional positive data from its pivotal Phase III clinical trial, MS-SPI, with MD1003, a highly-concentrated pharmaceutical grade biotin, in patients with Progressive Multiple Sclerosis.
In an early step toward letting severely paralyzed people speak with their thoughts, University of Utah researchers translated brain signals into words using two grids of 16 microelectrodes implanted beneath the skull but atop the brain. "We have been able to decode spoken words using only signals from the brain with a device that has promise for long-term use in paralyzed patients who cannot now speak," says Bradley Greger, an assistant professor of bioengineering.
Researchers from Chronix Biomedical and The University of Texas MD Anderson Cancer Center today announced that results from a pilot study demonstrating the utility of cell-free DNA (cfDNA) blood tests as a companion diagnostic for breast cancer patients are to be reported in a poster presentation titled "Modulation of breast cancer cell-free DNA with surgical resection" (Abstract #11060) at the American Society of Clinical Oncology Annual Meeting (ASCO 2013) being held from May 31 through June 4, 2013 in Chicago. The blood test detects cfDNA that is released into the blood stream by damaged and dying cancer cells.
› Verified 4 days ago
Aimee Liu, OD Optometrist Medicare: Medicare Enrolled Practice Location: 15600 Ne 8th St Ste F13a, Bellevue, WA 98008 Phone: 425-641-7482 Fax: 425-505-2156 | |
Britlynn Chan, O.D. Optometrist Medicare: Medicare Enrolled Practice Location: 11120 Ne 33rd Pl, Bellevue, WA 98004 Phone: 206-426-2584 | |
Adl Vision Llc Optometrist Medicare: Medicare Enrolled Practice Location: 15600 Ne 8th St Ste F13a, Bellevue, WA 98008 Phone: 425-641-7482 Fax: 425-505-2156 | |
Thomas Xie, Optometrist Medicare: Not Enrolled in Medicare Practice Location: 1020 108th Ave Ne Apt 1401, Bellevue, WA 98004 Phone: 347-687-0712 | |
Dr. Grant Edward Lindberg, OD Optometrist Medicare: Accepting Medicare Assignments Practice Location: 12310 Ne 8th St, Suite 101, Bellevue, WA 98005 Phone: 425-455-0001 Fax: 425-462-7387 | |
Joanna Stedman Haws, O.D. Optometrist Medicare: Accepting Medicare Assignments Practice Location: 12310 Ne 8th St, Suite 101, Bellevue, WA 98005 Phone: 425-455-0001 Fax: 425-462-7387 | |
Dr. Theodore Stephen Kadet, O.D. Optometrist Medicare: Not Enrolled in Medicare Practice Location: 14030 Ne 24th St, Suite 101, Bellevue, WA 98007 Phone: 425-462-7800 Fax: 425-455-3019 |